Rabbit Polyclonal ATPBD3 antibody. Suitable for WB and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human CTU1.
View Alternative Names
ATPBD3, NCS6, CTU1, Cytoplasmic tRNA 2-thiolation protein 1, ATP-binding domain-containing protein 3, Cancer-associated gene protein, Cytoplasmic tRNA adenylyltransferase 1
- WB
Unknown
Western blot - Anti-ATPBD3 antibody (AB136083)
All lanes:
Western blot - Anti-ATPBD3 antibody (ab136083) at 1/500 dilution
All lanes:
293 cell lysate at 30 µg
Predicted band size: 36 kDa
false
- WB
CiteAb
Western blot - Anti-ATPBD3 antibody (AB136083)
ATPBD3 western blot using anti-ATPBD3 antibody ab136083. Publication image and figure legend from Trzaska, C., Amand, S., et al., 2020, Nat Commun, PubMed 32198346.
ab136083 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab136083 please see the product overview.
DAP interferes with the activity of FTSJ1.a Determination by tandem mass spectrometry of the amino acid incorporated at the PTC position. Firefly luciferase from HEK293FT cells transfected with the Fluc-int-UGA construct was immunoprecipitated and digested with trypsin. The MS/MS spectrum of the peptide containing the PTC position and the sequence determination are shown. The upper red and blue sequences indicate the amino acids validated, respectively, by detection of Nter and Cter peptide fragments (b and y ion series). Peptide fragments y6 and y7 clearly identify tryptophan (W) at the PTC position. The black peaks correspond to non-attributed mass-to-charge ratio (m/z) values. The green peaks are internal fragments that do not contain an extremity of the peptide. b The efficiency of UGA readthrough by DAP decreases with increasing amounts of FTSJ1 but not with increasing amounts of CTU1. Readthrough efficiency was determined by measuring luciferase activity in HeLa cells co-transfected with the firefly luciferase construct described in Fig. 1b and with increasing amounts of an expression vector for either FTSJ1 or CTU1 (0.5, 1, or 2 µg). The empty expression vector (E.v.) was used as control. The cells were then exposed to 0, 0.39, 0.78, 1.56, 6.25, 25, 100, 300, or 600 µM DAP for 24 h before measuring the luciferase activity. The experiment was performed twice and the results of both experiments (Exp1 and Exp2) are shown. c Western blot analysis of FTSJ1 and CTU1. d 2′-O-methylation analysis of tRNATrp, tRNASER, and tRNAGLN by RiboMethSeq. HeLa cells were incubated for 24 h with DMSO or with 25 µM DAP. A MethScore was attributed to each tRNA 2′-O-methylation in tRNA purified from HeLa cells treated with DAP (dark green histogram) or DMSO (light green histogram). The results of three independent experiments are indicated with the symbols square, point, or triangle. e Analysis of DAP affinity column eluates shows that DAP interacts with FTSJ1. HeLa-cell extract was incubated with DAP covalently bound to beads or with beads alone. Proteins bound to the columns were eluted with excess DAP and the eluates analyzed by western blot. A molecular weight marker is indicated to the left of each gel. p-values (p) were calculated using Student’s t-test. Source data are provided as a Source Data file.
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ATPBD3 facilitates energy homeostasis and cellular metabolic processes. It performs as part of a complex that coordinates multiple cellular activities ensuring efficient energy production and utilization. This precise management of cellular energy resources is important for supporting cell survival promoting cell growth and regulating apoptosis. Through these activities ATPBD3 contributes significantly to maintaining cellular homeostasis and responding to metabolic demands.
Pathways
ATPBD3 integrates into cellular energy metabolism and stress response pathways. It engages in ATP synthesis and hydrolysis processes critical for energy production and cellular adaptation. The protein functions alongside other metabolic enzymes like AMP-activated protein kinase (AMPK) which senses cellular energy status and regulates metabolic pathways. ATPBD3's role in these pathways showcases its involvement in cellular responses to energy fluctuations aiding cells in adapting to metabolic shifts.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 11:1509 PubMed32198346
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 10:5492 PubMed31792210
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 9:3925 PubMed30254264
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com